The therapeutic candidacy of circRNA ACTA2 was also demonstrated in these mechanistic studies; however, there has not yet been any investigation of circRNA ACTA2 as a biomarker for cardiac fibrosis or heart disease. The gene discussed is ACTA2; the disease is heart disorder.